Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by allibabbaon Oct 22, 2021 1:07pm
85 Views
Post# 34038049

RE:RE:A good algorithm program running on a trading

RE:RE:A good algorithm program running on a trading While your comments may have some logic to them, it's not all common sense.  Labs has well over 20 million in receivables that they are counting as money in the bank which they may never get (hexo lawsuit).  If they lose that and the cash burn continues, it's bye bye cash and more dilution.  That's what the pros are betting on for now.  Their revenues have cratered and now are staying flat.  So although it seems like a bargain now, it could be a very different picture in the near future.  Fingers crossed the ship can be lifted from the muck.
<< Previous
Bullboard Posts
Next >>